论文部分内容阅读
美国洛克菲勒基金委员会人口科学部的主任Sheldon J Segal说,他们试制男用避孕药已有25年,采用了现代医学的所有尖端技术,但一无所获。然而。目前有两项领先的研究提供了希望。两种方法均已进行到人类试验的早期阶段,其中之一或二者均可于十年内在市场出售。新的研究之一,脑内促黄体化激素释放激素(LHRH)是具有基本生物学重要性的系统科学研究的产物,此项研究人员曾获得诺贝
Sheldon J Segal, director of the Department of Population Science at the Rockefeller Foundation Committee in the United States, said that they have experimented with male contraception for 25 years and used all the cutting-edge technology in modern medicine but got nothing. however. There are currently two leading studies that offer hope. Both approaches have been conducted in the early stages of human trials, either or both of which can be put on the market within 10 years. One of the new studies, luteinizing hormone releasing hormone (LHRH) in the brain, is a product of a systematic scientific study of fundamental biological importance that the researchers obtained